JENNIFER LOVELESS to Societies, Medical
This is a "connection" page, showing publications JENNIFER LOVELESS has written about Societies, Medical.
Connection Strength
0.354
-
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Asymptomatic Histoplasma Pulmonary Nodules (Histoplasmomas) and Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant People. Clin Infect Dis. 2026 Jan 16; 81(Supplement_3):i27-i32.
Score: 0.177
-
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Histoplasmosis: Treatment of Mild or Moderate Acute Pulmonary Histoplasmosis in Adults, Children, and Pregnant People. Clin Infect Dis. 2026 Jan 16; 81(Supplement_3):i39-i45.
Score: 0.044
-
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness. Clin Infect Dis. 2026 Jan 16; 81(Supplement_3):i1-i5.
Score: 0.044
-
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab. Clin Infect Dis. 2026 Jan 16; 81(Supplement_3):i22-i26.
Score: 0.044
-
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept. Clin Infect Dis. 2026 Jan 16; 81(Supplement_3):i17-i21.
Score: 0.044